These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23453879)

  • 1. Left ventricular diastolic dysfunction and thromboembolic risk in atrial fibrillation: diastolic dysfunction and thromboembolic risk in AF.
    Kosiuk J; Breithardt O; Bode K; Kornej J; Arya A; Gaspar T; Hindricks G; Bollmann A
    Int J Cardiol; 2013 Sep; 168(1):547-8. PubMed ID: 23453879
    [No Abstract]   [Full Text] [Related]  

  • 2. Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function.
    Cha YM; Wokhlu A; Asirvatham SJ; Shen WK; Friedman PA; Munger TM; Oh JK; Monahan KH; Haroldson JM; Hodge DO; Herges RM; Hammill SC; Packer DL
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):724-32. PubMed ID: 21747059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diastolic dysfunction and risk of atrial fibrillation: a mechanistic appraisal.
    Rosenberg MA; Manning WJ
    Circulation; 2012 Nov; 126(19):2353-62. PubMed ID: 23129702
    [No Abstract]   [Full Text] [Related]  

  • 4. High concentrations of B-type natriuretic peptide and left ventricular diastolic dysfunction in patients with paroxysmal/persistent atrial fibrillation as possible markers of conversion into permanent form of arrhythmia: 1-year prospective evaluation.
    Dabrowski R; Borowiec A; Janas J; Firek B; Kowalik I; Smolis-Bak E; Luczak D; Sosnowski C; Kazimierska B; Szwed H
    Kardiol Pol; 2010 Aug; 68(8):893-900. PubMed ID: 20730719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular diastolic dysfunction in atrial fibrillation: predictors and relation with symptom severity.
    Kosiuk J; Van Belle Y; Bode K; Kornej J; Arya A; Rolf S; Husser D; Hindricks G; Bollmann A
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1073-7. PubMed ID: 22672521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular hypertrophy determines the severity of diastolic dysfunction in patients with nonvalvular atrial fibrillation and preserved left ventricular systolic function.
    Moon J; Rim SJ; Cho IJ; Lee SH; Choi S; Chung WJ; Byun YS; Ryu SK; Pyun WB; Kim JY
    Clin Exp Hypertens; 2010; 32(8):540-6. PubMed ID: 21091364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic risk evaluation in patients with atrial fibrillation using a modified CHADS(2) scoring system.
    Cha MJ; Oh GC; Hahn S; Choi EK; Oh S
    J Cardiovasc Electrophysiol; 2012 Feb; 23(2):155-62. PubMed ID: 21955174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can thromboembolic risk be associated with erectile dysfunction in atrial fibrillation patients?
    Szymański FM; Filipiak KJ; Płatek AE; Kotkowski M; Opolski G
    Cardiol J; 2015; 22(4):446-52. PubMed ID: 25733318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A risk score for predicting atrial fibrillation in individuals with preclinical diastolic dysfunction: a retrospective study in a single large urban center in the United States.
    Li DL; Quispe R; Madan N; Zhang L; Taub CC
    BMC Cardiovasc Disord; 2019 Feb; 19(1):47. PubMed ID: 30813895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation. The prospective Danish Diet, Cancer and Health study.
    Overvad TF; Rasmussen LH; Skjøth F; Overvad K; Albertsen IE; Lane DA; Lip GY; Larsen TB
    Thromb Haemost; 2014 Oct; 112(4):789-95. PubMed ID: 25055988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of sex differences in the relationship between diastolic dysfunction and thromboembolism using propensity score analysis.
    Kim MN; Shim JM; Choi JI; Park SM; Kim YH; Shim WJ
    Echocardiography; 2018 Jun; 35(6):817-826. PubMed ID: 29460490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant therapy is prescribed less often in paroxysmal atrial fibrillation regardless of thromboembolic risk: results from the Registry of Atrial Fibrillation To Investigate New Guidelines (RAFTING).
    Pipilis A; Farmakis D; Kaliambakos S; Antoniou A; Goudevenos J; Lekakis J;
    Int J Cardiol; 2014 Aug; 175(3):569-70. PubMed ID: 24874899
    [No Abstract]   [Full Text] [Related]  

  • 13. Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study.
    Fangel MV; Nielsen PB; Larsen TB; Christensen B; Overvad TF; Lip GYH; Goldhaber SZ; Jensen MB
    Int J Cardiol; 2018 Oct; 268():137-142. PubMed ID: 30041778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the reliability and validity of four contemporary risk stratification schemes to predict thromboembolism in non-anticoagulated patients with atrial fibrillation.
    Abu-Assi E; Otero-Raviña F; Allut Vidal G; Coutado Méndez A; Vaamonde Mosquera L; Sánchez Loureiro M; Caneda Villar MC; Fernández Villaverde JM; Maestro Saavedra FJ; González-Juanatey JR;
    Int J Cardiol; 2013 Jun; 166(1):205-9. PubMed ID: 22104995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged atrial effective refractory periods in atrial fibrillation patients associated with structural heart disease or sinus node dysfunction compared with lone atrial fibrillation.
    Uhm JS; Mun HS; Wi J; Shim J; Joung B; Lee MH; Pak HN
    Pacing Clin Electrophysiol; 2013 Feb; 36(2):163-71. PubMed ID: 23121003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diastolic dysfunction predicts new-onset atrial fibrillation and cardiovascular events in patients with acute myocardial infarction and depressed left ventricular systolic function: a CARISMA substudy.
    Jons C; Joergensen RM; Hassager C; Gang UJ; Dixen U; Johannesen A; Olsen NT; Hansen TF; Messier M; Huikuri HV; Thomsen PE
    Eur J Echocardiogr; 2010 Aug; 11(7):602-7. PubMed ID: 20304839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events.
    Botto GL; Padeletti L; Santini M; Capucci A; Gulizia M; Zolezzi F; Favale S; Molon G; Ricci R; Biffi M; Russo G; Vimercati M; Corbucci G; Boriani G
    J Cardiovasc Electrophysiol; 2009 Mar; 20(3):241-8. PubMed ID: 19175849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation.
    Stulak JM; Deo S; Schirger J; Aaronson KD; Park SJ; Joyce LD; Daly RC; Pagani FD
    Ann Thorac Surg; 2013 Dec; 96(6):2161-7. PubMed ID: 24035302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Prostran MS; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):319-26. PubMed ID: 22319004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diastolic dysfunction and atrial fibrillation].
    Loboz-Grudzień K
    Kardiol Pol; 2010 Aug; 68(8):901-2. PubMed ID: 20730720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.